Literature DB >> 31056611

CLINICAL AND BIOMEDICAL APPLICATIONS OF SURFACE PLASMON RESONANCE SYSTEMS.

David E Meza-Sánchez1, José L Maravillas-Montero1.   

Abstract

Surface plasmon resonance (SPR)-based biosensors offer superior analytical features such as simplicity, sensitivity, and specificity when compared to conventional methods in clinical analyses. In addition, they deliver real-time monitoring of label-free analytes with high-throughput approaches requiring little sample pretreatment that allows the analysis of virtually every clinical sample type to determine the amount and/or activity of any molecule of interest. Accordingly, SPR emerges as a novel, efficient, powerful, and relatively low-cost alternative tool for routine clinical analysis, opening also new horizons for developments in personalized medicine applied to diagnostics or therapeutics' monitoring. Copyright:
© 2019 SecretarÍa de Salud.

Keywords:  Biomarker; Clinical diagnostics; Surface plasmon resonance

Mesh:

Year:  2019        PMID: 31056611     DOI: 10.24875/RIC.18002754

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  2 in total

Review 1.  Label-Free MicroRNA Optical Biosensors.

Authors:  Meimei Lai; Gymama Slaughter
Journal:  Nanomaterials (Basel)       Date:  2019-11-06       Impact factor: 5.076

2.  N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease.

Authors:  Lucy K Shewell; Christopher J Day; Jamie R Kutasovic; Jodie L Abrahams; Jing Wang; Jessica Poole; Colleen Niland; Kaltin Ferguson; Jodi M Saunus; Sunil R Lakhani; Mark von Itzstein; James C Paton; Adrienne W Paton; Michael P Jennings
Journal:  BMC Cancer       Date:  2022-03-26       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.